Ajinomoto Bio-Pharma Services vs FUJIFILM Diosynth Biotechnologies: CDMO Comparison
How does Ajinomoto Bio-Pharma Services compare to FUJIFILM Diosynth Biotechnologies?
As of Oct 2026, Ajinomoto Bio-Pharma Services: no FDA inspections on file, 1 EMA/MHRA GMP certificate. Signal Score 83.5. FUJIFILM Diosynth Biotechnologies: no FDA inspections on file, 35 EMA/MHRA GMP certificates. Signal Score 86.7. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of Ajinomoto Bio-Pharma Services and FUJIFILM Diosynth Biotechnologies on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- FUJIFILM Diosynth Biotechnologies holds 29 active EMA GMP certificates; Ajinomoto Bio-Pharma Services does not appear in EudraGMDP.
- FUJIFILM Diosynth Biotechnologies has stronger MHRA / UK coverage (6 compliant certificates vs 1).
Across the cross-modality scorecard, FUJIFILM Diosynth Biotechnologies carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: Ajinomoto Bio-Pharma Services vs FUJIFILM Diosynth Biotechnologies
How does Ajinomoto Bio-Pharma Services compare to FUJIFILM Diosynth Biotechnologies?
On CDMO Signal's composite Signal Score, Ajinomoto Bio-Pharma Services is 84/100 and FUJIFILM Diosynth Biotechnologies is 87/100; European coverage is 1 active EMA+MHRA certificate for Ajinomoto Bio-Pharma Services vs 35 for FUJIFILM Diosynth Biotechnologies. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
How do Ajinomoto Bio-Pharma Services and FUJIFILM Diosynth Biotechnologies compare on European GMP coverage?
Ajinomoto Bio-Pharma Services holds 0 active EMA GMP certificates and 1 MHRA / UK certificate. FUJIFILM Diosynth Biotechnologies holds 29 active EMA GMP certificates and 6 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
What does the Signal Score gap mean in practice?
Ajinomoto Bio-Pharma Services carries a Signal Score of 84/100 and FUJIFILM Diosynth Biotechnologies carries 87/100 — essentially tied for FUJIFILM Diosynth Biotechnologies. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →